期刊文献+

直肠癌患者手术前后外周血髓源抑制性细胞比例及其与预后的关系 被引量:1

Relationship of preoperative and postoperative myeloid-derived suppressor cells percentage with the prognosis in rectal cancer patients
原文传递
导出
摘要 目的观察直肠癌患者手术前后外周血中髓源抑制性细胞(MDSC)比例的动态变化,并探讨MDSC比例与患者预后的关系。方法收集郑州大学附属肿瘤医院普通外科2009年1—12月间收治的64例Ⅰ~Ⅲ期直肠癌患者术前及术后21d的全血标本,通过流式细胞法检测MDSC比例.并分析其与患者预后的关系。结果术后21d,直肠癌患者MDSC比例较术前明显降低(P〈0.01),但发生局部复发或远处转移时,MDSC比例再次增高(均P〈0.01)并接近术前水平(均P〉0.05)。以中位数为界,术前MDSC比例较高组(大于3.78%)及术后MDSC比例较高组(大于2.11%)的5年总体生存率(分别为58.1%和62.1%)和5年无病生存率(分别为54.8%和58.6%)均显著低于术前及术后MDSC比例较低组(分别为87.9%和84.8%以及82.8%和80.0%,均P〈0.05)。多因素预后分析显示.术前MDSC比例为直肠癌患者总体生存的独立预后指标(HR=4.065,95%CI:1.026~16.108,P=0.04)。结论直肠癌患者术前外周血MDSC比例升高预后不良;MDSC比例的动态变化或可反映疾病进展情况。 Objective To observe the change of myeloid-derived suppressor cells (MDSCs) percentage in peripheral blood after operation in rectal cancer patients and to examine its association with the prognosis. Methods Blood samples of pre-operation and postoperative 21-day from 64 stage Ⅰ~Ⅲ rectal cancer patients who underwent surgery in Department of General Surgery, The Affiliated Cancer Hospital, Zhengzhou University between January and December 2009 were collected. MDSCs percentage was detected by flow cytometry. Its association with the prognosis of patients was analyzed. Results MDSCs percentage of postoperative 21-day decreased significantly compared with pre-operation (P〈0.01). When local recurrence or distant metastasis presented, MDSCs percentage increased again (all P〈0.01 ) and reached the preoperative level(P〉0.05). All the patients were further divided into two groups based on median MDSCs percentage. Patients with higher MDSCs percentage before operation (〉 3.78% ) and after operation (〉2.11% ) had significantly lower 5-year overall survival (OS) (58.1% and 62.1%) and 5-year disease-free survival (DFS) (54.8% and 58.6%) as compared to those with lower MDSCs percentage (5-year OS 87.9% and 84.8%; 5-year DFS 82.8% and 80.0%, all P〈0.05). Multivariate analysis showed that preoperative MDSCs percentage was an independent prognostic factor of rectal cancer (HR:4.065, 95% CI:1.026 to 16.108, P=0.04). Conclusions Preoperative increased MDSCs percentage may be an important predictor of poor OS in rectal cancer patients. Dynamic change of MDSCs percentage can reflect the disease development.
出处 《中华胃肠外科杂志》 CAS CSCD 北大核心 2015年第11期1139-1143,共5页 Chinese Journal of Gastrointestinal Surgery
基金 河南省医学科技攻关计划重大项目(201001013,201401016)
关键词 直肠肿瘤 髓源抑制性细胞 预后 Rectal neoplasms Myeloid-derived suppressor cells Prognosis
  • 相关文献

参考文献15

  • 1Kunitake H,Abbas MA. Transanal endoscopic microsurgery forrectal tumors: a review[J]. Perm J, 2012,16:45-50.
  • 2吴叶娇,易洪刚.结肠直肠癌全基因组关联的研究进展[J].中华流行病学杂志,2013,34(10):1035-1039. 被引量:4
  • 3Gabrilovich DI, Nagaraj S. Myeloid-derived suppressor cells asregulators of the immune system [J]. Nat Rev Immunol, 2009,9:162-174.
  • 4Ostrand-Rosenberg S, Sinha P. Myeloid-derived suppressorcells: linking inflammation and cancer [J]. J Immunol, 2009,182:4499-4506.
  • 5Ostrand-Rosenberg S. Myeloid-derived suppressor cells: moremechanisms for inhibiting antitumor immunity [J]. CancerImmunol Immunother, 2010,59: 1593-1600.
  • 6Gabrilovich DI, Bronte V, Chen SH, et al. The terminologyissue for myeloid-derived suppressor cells [J]. Cancer Res, 2007,64-425-426.
  • 7Diaz-Montero CM, Salem ML, Nishimura MI, et al. Increasedcirculating myeloid-derived suppressor cells correlate withclinical cancer stage,metastatic tumor burden,and doxombicin-cyclophosphamide chemotherapy [ J]. Cancer Immunol Immunother,2009,58:49-59.
  • 8Gabitass RF,Annels NE, Stocken DD, et al. Elevatedmyeloid-derived suppressor cells in pancreatic,esophageal andgastric cancer are an independent prognostic factor and areassociated with significant elevation of the Th2 cytokineinterleukin-13 [J]. Cancer Immunol Immunother, 2011,60: 1419-1430.
  • 9Murdoch C, Muthana M, Coffelt SB, et al. The role of myeloidcells in the promotion of tumour angiogenesis [J]. Nat RevCancer, 2008,8:618-631.
  • 10Yang L, DeBusk LM, Fukuda K, et al. Expansion of myeloidimmune suppressor Gr +CDllb + cells in tumor-bearing hostdirectly promotes tumor angiogenesis [J]. Cancer Cell, 2004,6:409-421.

二级参考文献58

  • 1Parkin DM. Global cancer statistics in the year 2000. Lancet Oncol,2001,2(9) :533-543.
  • 2Jemal A, Center MM, DeSantis C, et al. Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev,2010,19(8) : 1893-1907.
  • 3Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin, 2011,61 (2) : 69-90.
  • 4Lichtenstein P,HolmNV, Verkasalo PK, et al. Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med, 2000,343 (2) : 78-85.
  • 5lies MM. What can genome-wide association studies tell us about the genetics of common disease? PLoS Genet,2008,4(2) :e33.
  • 6McCarthy MI,Abecasis GR,Cardon LR, et al. Genome-wide association studies for complex traits: consensus, uncertainly and challenges. Nat Rev Genet, 2008,9 (5) : 356-369.
  • 7Hardy J, Singleton A. Genomewide association studies and human disease. N Engl J Med,2009,360(17) : 1759-1768.
  • 8Teo YY. Common statistical issues in genome-wide association studies: a review on power, data quality control, genotype calling and population structure. Curr Opin Lipidol, 2008,19 (2) : 133 - 143.
  • 9Chanock S J, Manolio T, Boehnke M, et al. Replicating genotype-phenotype associations. Nature, 2007,447 (7145 ) : 655-660.
  • 10Risch N, Merikangas K. The future of genetic studies of complex human diseases. Science, 1996,273(5281 ) : 1516-1517.

共引文献3

同被引文献3

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部